By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Life Technologies will commercialize Gen-Probe's Elucigene QST*R aneuploidy test kits under the Applied Biosystems name in certain markets around the world, the firm announced over the weekend.

Life Technologies will sell the test kits in Eastern Europe, Asia, Africa, Australia, Latin America, and Canada, under the agreement. However, the kits will not be available for sale in the US.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.

Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.

Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.

In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.